PTIX (STOCKS)
PROTAGENIC THERAPEUTICS
$0.360000
+0.040000 (+12.50%)
Prev close: $0.320000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- —
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6.22M
- Employees
- 3
- P/E (TTM)
- -2.02
- P/B (TTM)
- 0.87
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2025 (Q1)
|
$-2.75 | $0.00 | +0.0000 | +0.00% |
|
Dec 2024 (Q4)
|
$-0.24 | $0.00 | +0.0000 | +0.00% |
|
Jun 2024 (Q2)
|
$-0.36 | $0.00 | +0.0000 | +0.00% |
|
Sep 2023 (Q3)
|
$-0.32 | $0.00 | +0.0000 | +0.00% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $675.23K |
| Operating Expenses | $5.83M |
| Research and Development | $1.70M |
| Other Operating Expenses | $4.13M |
| Operating Income/Loss | -$5.83M |
| Income/Loss From Continuing Operations After Tax | -$5.16M |
| Income/Loss From Continuing Operations Before Tax | -$5.16M |
| Net Income/Loss | -$5.16M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$5.16M |
| Net Income/Loss Available To Common Stockholders, Basic | -$5.16M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.25 |
| Diluted Earnings Per Share | -$4.25 |
| Basic Average Shares | 2,999,594 |
| Diluted Average Shares | 2,999,594 |
| Assets | $4.43M |
| Current Assets | $2.30M |
| Inventory | $1.07K |
| Other Current Assets | $2.30M |
| Noncurrent Assets | $2.13M |
| Liabilities | $6.82M |
| Current Liabilities | $6.82M |
| Accounts Payable | $2.03M |
| Other Current Liabilities | $4.79M |
| Noncurrent Liabilities | $0.00 |
| Equity | -$2.39M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$2.39M |
| Liabilities And Equity | $4.43M |
| Net Cash Flow From Operating Activities | -$4.14M |
| Net Cash Flow From Operating Activities, Continuing | -$4.14M |
| Net Cash Flow | $1.21M |
| Net Cash Flow, Continuing | $1.21M |
| Comprehensive Income/Loss | -$5.24M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$5.24M |
| Other Comprehensive Income/Loss | -$5.24M |